© Renub Research Page 1 of 15 Canada Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast Renub Research www.renub.com Published: April, 2015 Copyright © 2015 Renub Research – All Rights Reserved
© Renub Research Page 1 of 15
Canada Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast
Renub Researchwww.renub.com
Published: April, 2015Copyright © 2015 Renub Research – All Rights Reserved
© Renub Research Page 2 of 15
Canada Pediatric Vaccines Market Analysis
Pediatric vaccines market continues to be the success story for the manufacturers of pediatric
vaccines in Canada. The value of the Canada pediatric vaccines market is expected to be
slightly less than US$ 2 Billion by 2020. Pneumococcal vaccines (PCV) and Varicella vaccines
are the leading market share holder in Canada and together they contribute more than 50% of
the total Pediatric vaccines market. Polio, Measles, Mumps & Rubella (MMR), Diphtheria,
Tetanus & Pertussis (DTaP) cases have shown diminishing trends from the year 2001 till 2013.
On the contrary, in terms of Doses, Diphtheria, Tetanus & Pertussis(DTaP) and
Pneumococcal vaccines (PCV) have the highest number of doses in 2014.Diphtheria, Tetanus &
Pertussis(DTap) and Polio are the highly penetrated vaccines in Canada pediatric vaccines
market in 2014. It is predicted that these two vaccines will bolster the usable pattern in
Canada. Canada Pediatric vaccines are expected to remain highly active in the future, fueled
by the encouragement and financing from Governments and other health organizations. Canada
Pediatric vaccines market is driven by favorable demographics, growing public acceptance and
product innovation.
This is Renub Research 7th edition report on Vaccines Market & 2nd edition on Pediatric
Vaccines Sector. Report titled "Canada Pediatric Vaccines Market, Doses, Immunization
(Vaccinated), Cases & Forecast” talks about the pediatric vaccines scenario in Canada. This
report provides information on Eight (8) segments of Pediatric Vaccines Market, Pediatric
Vaccines Doses, Pediatric Vaccines number of Children Being Vaccinated and Number of Cases
in Canada. This report covers in detail all aspects of Past, Present and Future Scenario. The
report also entails major factors driving the Pediatric Vaccines Market and Challenges of
Canada Pediatric Vaccines Market.
8 Pediatric Vaccines Covered in this Report are as follows:
1. Measles, Mumps & Rubella (MMR) Vaccines
2. Haemophilus Influenzae Type B (HIB) Vaccines
3. Polio Vaccines
4. Diphtheria, Tetanus & Pertussis (DTaP) Vaccines
5. Pneumococcal Vaccines
© Renub Research Page 3 of 15
6. Hepatitis B Pediatric Vaccines
7. Varicella / Chicken Pox Vaccines
8. Meningococcal C Conjugate (Men–C) Vaccines
All the Pediatric Vaccines in this Report have been studied from Four View Points:
Number of Cases
Number of Doses
Number of Children Being Vaccinated
Market Size for all 8 Pediatric Vaccines
Data Sources
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–
printable sources like search engines, News websites, Government websites, Trade Journals,
White Papers, Government Agencies, Magazines, Newspapers, Trade Associations, Books,
Industry Portals, Industry Associations and access to more than 500 paid databases.
© Renub Research Page 4 of 15
About Us
RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with
centers at Noida India and Roswell USA. We have long–term experience especially in
international Business–to–Business Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information Technology
(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,
Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer
Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio–Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in today’s ultra–competitive markets.
For more information on us or to view any of our sample work you can mail
us at [email protected]
© Renub Research Page 5 of 15
Published
By
RReennuubb RReesseeaarrcchh
A–116B, Sector–27
Noida – 201301
Phone: +91–120–421–9822, 254–5750 (India)
+1–678–302–0700 (USA)
Fax : +91–120–424–9780
Email: [email protected]
Website: www.renub.com
© Canada Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast
Renub Research, 2015
Edition 2.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers
© Renub Research Page 6 of 15
Table of Contents
1. Executive Summary
2. Canada – Pediatric Vaccines Market & Forecast
3. Canada – Pediatric Vaccines Market Share & Forecast
4. Canada – Pediatric Vaccines Cases, Doses, Immunization Coverage, Market & Forecast
4.1 Canada – Measles, Mumps & Rubella (MMR) Vaccines & Forecast
4.1.1 Number of Measles, Mumps & Rubella (MMR) Cases
4.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses
4.1.3 Measles, Mumps & Rubella (MMR) – Number of Children Being Vaccinated
4.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines
4.2 Canada – Haemophilus Influenzae Type B (HIB) Vaccines & Forecast
4.2.1 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses
4.2.2 Haemophilus Influenzae Type B (HIB) – Number of Children Being Vaccinated
4.2.3 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines
4.3 Canada – Polio Vaccines & Forecast
4.3.1 Number of Polio Cases
4.3.2 Number of Polio Vaccines Doses
4.3.3 Polio Vaccines – Number of Children Being Vaccinated
4.3.4 Market Size of Polio Vaccines
4.4 Canada – Diphtheria, Tetanus & Pertussis (DTaP) Vaccines & Forecast
4.4.1 Number of Diphtheria, Tetanus & Pertussis (DTaP) Cases
4.4.2 Number of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Doses
4.4.3 Diphtheria, Tetanus & Pertusis (DTaP) – Number of Children Being Vaccinated
4.4.4 Market Size of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines
4.5 Canada – Pneumococcal Vaccines & Forecast
4.5.1 Number of Pneumococcal Vaccines Doses
4.5.2 Pneumococcal – Number of Children Being Vaccinated
4.5.3 Market Size of Pneumococcal Vaccines
4.6 Canada – Hepatitis B Pediatric Vaccines & Forecast
4.6.1 Number of Hepatitis B Pediatric Vaccines Doses
4.6.2 Hepatitis B Pediatric – Number of Children Being Vaccinated
4.6.3 Market Size of Hepatitis B Pediatric Vaccines
4.7 Canada – Varicella / Chicken Pox Vaccines & Forecast
© Renub Research Page 7 of 15
4.7.1 Number of Varicella / Chicken Pox Vaccines Doses
4.7.2 Varicella / Chicken Pox – Number of Children Being Vaccinated
4.7.3 Market Size of Varicella / Chicken Pox Vaccines
4.8 Canada – Meningococcal C (Men–C) Vaccines & Forecast
4.8.1 Number of Meningococcal C (Men–C) Vaccines Doses
4.8.2 Meningococcal C (Men–C) – Number of Children Being Vaccinated
4.8.3 Market Size of Meningococcal C (Men–C) Vaccines
5. Growth Drivers of Canada Pediatric Vaccines Market
5.1 Immunization & Reduce Preventable Infectious Diseases
5.1.1 Immunization — a Collective Protection
5.1.2 Immunization in Public Health — Past & Present
5.1.3 Immunization—a Shared Responsibility
5.2 The Vaccine Injury Compensation Program
5.3 Transforming of Vaccine Technologies
5.4 Continuous Focus on Effective Communication Strategies
6. Challenges of Canada Pediatric Vaccines Market
6.1 Impediment in Pediatric Vaccine Research & Development
6.2 Barriers to New Entrants in the Pediatric Vaccines Market
6.3 Hurdles to Optimal use of Licensed Vaccines
6.3.1 Technical Obstacles
6.3.2 Economic obstacles
6.3.3 Cultural Obstacles
6.4 Complexity of Vaccine Development & Approval System Thwarts Product Development
6.4.1 Legal Obstacles
6.4.2 General Technical Barriers
6.4.3 Economic Barriers
6.4.4 Regulatory Barriers
6.5 Shortening the Timeline for Vaccine Development
© Renub Research Page 8 of 15
List of Figures
Figure 2–1: Canada – Pediatric Vaccines Market (Million US$), 2010 – 2014
Figure 2–2: Canada – Forecast for Pediatric Vaccines Market (Million US$), 2015 – 2020
Figure 3–1: Canada – Pediatric Vaccines Market Share (Percent), 2010 – 2014
Figure 3–2: Canada – Forecast for Pediatric Vaccines Market Share (Percent), 2015 – 2020
Figure 4–1: Canada – Number of MMR Vaccines Doses (Million Doses), 2010 – 2014
Figure 4–2: Canada – Forecast for Number of MMR Vaccines Doses (Million Doses), 2015 – 2020
Figure 4–3: Canada – Number of Children Being Vaccinated with MMR Vaccines (Million), 2010 – 2014.
......................................................................................................... Error! Bookmark not defined.
Figure 4–4: United States – Forecast for Number of Children Being Vaccinated with MMR Vaccines
(Million), 2015 – 2020
Figure 4–5: Canada – Measles, Mumps & Rubella (MMR) Vaccines Market (Million US$), 2010 – 2014
......................................................................................................... Error! Bookmark not defined.
Figure 4–6: Canada – Forecast for Measles, Mumps & Rubella (MMR) Vaccines Market (Million US$),
2015 – 2020
Figure 4–7: Canada – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2010
– 2014
Figure 4–8: Canada – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million
Doses), 2015 – 2020
Figure 4–9: Canada – Number of Children Being Vaccinated with Haemophilus Influenzae Type B
Vaccines (Million), 2010 – 2014
Figure 4–10: Canada – Forecast for Number of Children Being Vaccinated with Haemophilus Influenzae
Type B Vaccines (Million), 2015 – 2020
Figure 4–11: Canada – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2010 – 2014
Figure 4–12: Canada – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$),
2015 – 2020
Figure 4–13: Canada – Number of Doses of Polio Vaccines (Million Doses), 2010 – 2014
Figure 4–14: Canada – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2015 – 2020
......................................................................................................... Error! Bookmark not defined.
Figure 4–15: Canada – Number of Children Being Vaccinated with Polio Vaccines (Million), 2010 – 2014
......................................................................................................... Error! Bookmark not defined.
Figure 4–16: Canada – Forecast for Number of Children Being Vaccinated with Polio Vaccines (Million),
2015 – 2020
Figure 4–17: Canada – Polio Vaccines Market (Million US$), 2010 – 2014
Figure 4–18: Canada – Forecast for Polio Vaccines Market (Million US$), 2015 – 2020
Figure 4–19: Canada – Number of Doses of DTaP Vaccines (Million Doses), 2010 – 2014
© Renub Research Page 9 of 15
Figure 4–20: Canada – Forecast for Number of Doses of DTaP Vaccines (Million Doses), 2015 – 2020
......................................................................................................... Error! Bookmark not defined.
Figure 4–21: Canada – Number of Children Being Vaccinated with DTaP Vaccines (Million Doses), 2010 –
2014
Figure 4–22: Canada – Forecast for Number of Children Being Vaccinated with DTap Vaccines (Million
Doses), 2015 – 2020
Figure 4–23: Canada – Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million US$), 2010 –
2014
Figure 4–24: Canada – Forecast for Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million
US$), 2015 – 2020
Figure 4–25: Canada – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2014
Figure 4–26: Canada – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2015 –
2020
Figure 4–27: Canada – Number of Children Being Vaccinated with Pneumococcal Vaccines (Million), 2010
– 2014
Figure 4–28: Canada – Forecast for Number of Children Being Vaccinated with Pneumococcal Vaccines
(Million), 2015 – 2020
Figure 4–29: Canada – Pneumococcal Vaccines Market (Million US$), 2010 – 2014
Figure 4–30: Canada – Forecast for Pneumococcal Vaccines Market (Million US$), 2015 – 2020
Figure 4–31: Canada – Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses), 2010 – 2014
......................................................................................................... Error! Bookmark not defined.
Figure 4–32: Canada – Forecast for Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses),
2015 – 2020
Figure 4–33: Canada – Number of Children Being Vaccinated with Hepatitis B Pediatric Vaccines (Million),
2010 – 2014
Figure 4–34: Canada – Forecast for Number of Children Being Vaccinated with Hepatitis B Pediatric
Vaccines (Million), 2015 – 2020
Figure 4–35: Canada – Hepatitis B Pediatric Vaccines Market (Million US$), 2010 – 2014
Figure 4–36: Canada – Forecast for Hepatitis B Pediatric Vaccines Market (Million US$), 2015 – 2020
Figure 4–37: Canada – Number of Doses of Varicella Vaccines (Million Doses), 2010 – 2014
Figure 4–38: Canada – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2015 – 2020
Figure 4–39: Canada – Number of Children Being Vaccinated with Varicella Vaccines (Million), 2010 –
2014
Figure 4–40: Canada – Forecast for Number of Children Being Vaccinated with Varicella Vaccines
(Million), 2015 – 2020
Figure 4–41: Canada – Varicella Vaccines Market (Million US$), 2010 – 2014
Figure 4–42: Canada – Forecast for Varicella Vaccines Market (Million US$), 2015 – 2020
© Renub Research Page 10 of 15
Figure 4–43: Canada – Number of Doses of Meningococcal C (Men–C) Vaccines (Million Doses), 2010 –
2014
Figure 4–44: Canada – Forecast for Number of Doses of Meningococcal C (Men–C) Vaccines (Million
Doses), 2015 – 2020
Figure 4–45: Canada – Number of Children Being Vaccinated with Meningococcal C (Men–C) Vaccines
(Million), 2010 – 2014
Figure 4–46: Canada – Forecast for Number of Children Being Vaccinated with Meningococcal C (Men–C)
Vaccines (Million), 2015 – 2020
Figure 4–47: Canada – Meningococcal C (Men–C) Vaccines Market (Million US$), 2010 – 2014
Figure 4–48: Canada – Forecast for Meningococcal C (Men–C) Vaccines Market (Million US$), 2015 –
2020
© Renub Research Page 11 of 15
List of Tables
Table 4–1: Canada – Number of Measles Cases (Number), 1999 – 2013
Table 4–2: Canada – Number of Mumps Cases (Number), 1999 – 2013
Table 4–3: Canada – Number of Rubella Cases (Number), 1999 – 2013
Table 4–4: Canada – Number of Polio Cases (Number), 2001 – 2013
Table 4–5: Canada – Number of Diphtheria Cases (Number), 1999 – 2013
Table 4–6: Canada – Number of nTetanus Cases (Number), 1999 – 2013
Table 4–7: Canada – Number of tTetanus Cases (Number), 1999 – 2013
Table 4–8: Canada – Number of Pertussis Cases (Number), 1999 – 2013
Table 5–1: Canada – Incidence of Selected Vaccine–preventable Disease, Pre–vaccine era compared with
Pre-Vaccine Era to 2013
Table 5–2: Improvement Strategies or Requirements – the Joint Commission and the Project’s
Collaborating Organizations
© Renub Research Page 12 of 15
Order Form
Scan and e-mail this page to [email protected], alternatively one can also write the Contact
Information in an e-mail and mail it.
Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to
Format
Report Title: Canada Pediatric Vaccines Market, Doses, Immunization
(Vaccinated), Cases & Forecast
Single User (Email from Publisher)
Hard Copy (Mail Delivery)
CD – Rom (Mail Delivery)
Global Site License (Multiple User License)
US$ 1,000 US$ 1,100 US$ 1,100 US$ 1,800
For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.):
http://www.renub.com/report/canada-pediatric-vaccines-market-doses-immunization-
vaccinated-cases-forecast-162
2) Order by Wire Transfer:
http://www.renub.com/report/wiretransfer.aspx?id=162&pid=1621
To pay by Wire Transfer, please, fill in your contact details in the form below:
© Renub Research Page 13 of 15
Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi – 110001
India
Contact Information
First Name: Last Name:
Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:
© Renub Research Page 14 of 15
3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
1st Floor
C-86, Sector -10
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780
For free Sample copy report or to view any of our sample work please contact us at
[email protected] or call +91-120-421-9822 (India), +1-678-302-0700 (USA)
Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090
LinkedIn: http://www.linkedin.com/company/renub-research
Twitter: http://twitter.com/RenubResearch
© Renub Research Page 15 of 15